340B Snapshot: Janssen's Discounts In US Program Have Risen 220% Over Past Five Years

 
• By Cathy Kelly

Janssen's 2021 US price transparency report offers insights into why the company recently joined the growing number of major pharma manufacturers who are restricting 340B discounts to contract pharmacies participating in the program.

Lots Of Money Is Swirling Around Rx Drugs In The Supply Chain • Source: Alamy

More from Medicaid

More from Government Payers